N-terminal-pro-brain natriuretic peptide, a surrogate biomarker of combined clinical and hemodynamic outcomes following percutaneous transvenous mitral commissurotomy

Krishna Kumar, 2013, Rheumatic fever and rheumatic heart disease: the last 50years, Indian J Med Res, 137, 643 Gardner, 2003, N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure, Eur Heart J, 24, 1735, 10.1016/j.ehj.2003.07.005 Bayes-Genis, 2007, Serial NT-proBNP monitoring and outcomes in outpatients with decompensation of heart failure, Int J Cardiol, 120, 338, 10.1016/j.ijcard.2006.10.009 Troughton, 2000, Treatment of heart failure guided by amino-terminal brain natriuretic peptide (N-BNP) concentrations, Lancet, 355, 1126, 10.1016/S0140-6736(00)02060-2 Bando, 1999, Elevated plasma brain natriuretic peptide levels in chronic respiratory failure with corpulmonale, Respir Med, 93, 507, 10.1016/S0954-6111(99)90094-X Nagaya, 1998, Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension, J Am Coll Cardiol, 31, 202, 10.1016/S0735-1097(97)00452-X Sharma, 2011, Comparison of atrial and brain natriuretic peptide for the assessment of mitral stenosis, Heart Lung Circ, 20, 517, 10.1016/j.hlc.2011.03.112 Pizarro, 2009, Prospective validation of the prognostic usefulness of brain natriuretic peptide in asymptomatic patients with chronic severe mitral regurgitation, J Am Coll Cardiol, 54, 1099, 10.1016/j.jacc.2009.06.013 Bergler-Klein, 2014, The role of biomarkers in valvular heart disease: focus on natriuretic peptides, Can J Cardiol, 30, 1027, 10.1016/j.cjca.2014.07.014 Tharaux, 1994, Plasma atrial and brain natriuretic peptides in mitral stenosis treated by valvulotomy, Clin Sci, 87, 671, 10.1042/cs0870671 Razzolini, 2002, Neurohormones in MS before and after percutaneous balloon mitral valvotomy, J Heart Valve Dis, 11, 185 Golbasy, 2004, Plasma B-type natriuretic peptide in patients with rheumatic heart disease, Eur J Heart Fail, 6, 757, 10.1016/j.ejheart.2004.04.018 Iltumur, 2005, NT pro B-type natriuretic peptide levels correlate with severity of mitral stenosis, J Heart Valve Dis, 74, 735 Arat-Ozkan, 2005, Serum NT pro B-type natriuretic peptide levels correlate with symptoms and echocardiographic findings in patients with mitral stenosis, Echocardiography, 22, 473, 10.1111/j.1540-8175.2005.04085.x Davutoglu, 2005, Plasma NT-proBNP is a potential marker of disease severity and correlates with symptoms in patients with chronic rheumatic valve disease, Eur J Heart Fail, 7, 532, 10.1016/j.ejheart.2004.07.006 Eryol, 2007, The relationship between the level of plasma B-type natriuretic peptide and mitral stenosis, Int J Cardiovasc Imaging, 23, 569, 10.1007/s10554-006-9174-8 Ucar, 2012, Valvular heart disease: plasma B-type natriuretic peptide levels in patients with pure rheumatic mitral stenosis, Acta Cardiol, 67, 59, 10.1080/AC.67.1.2146566 Shang, 2005, Effects of percutaneous balloon mitral valvuloplasty on plasma B-type natriuretic peptide in rheumatic mitral stenosis with and without atrial fibrillation, J Heart Valve Dis, 14, 453 Seluck, 2007, The effect of percutaneous balloon mitral valvuloplasty on N-terminal-proB-type natriuretic peptide plasma levels in mitral stenosis, Int Heart J, 48, 579, 10.1536/ihj.48.579 Chadha, 2010, N-terminal pro-BNP plasma levels before and after percutaneous transvenous mitral commissurotomy for mitral stenosis, Int J Cardiol, 144, 238, 10.1016/j.ijcard.2009.01.001 Nitin, 2010, Correlation between levels of NT-proBNP and cardiac function after percutaneous balloon mitral valvotomy in mitral stenosis, Calicut Med J, 8, e2 Pourafkari, 2014, Changes in serum NT-Pro BNP and left atrial BNP levels after percutaneous transvenous mitral commissurotomy in sinus rhythm versus atrial fibrillation, J Cardiovasc Thorac Res, 6, 175, 10.15171/jcvtr.2014.007 Esteves, 2013, The impact of right ventricular stroke work on B-type natriuretic peptide levels in patients with mitral stenosis undergoing percutaneous mitral valvuloplasty, J Interv Cardiol, 26, 501, 10.1111/joic.12050 Nishimura, 2014, AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines, J Am Coll Cardiol, 63, 2438, 10.1016/j.jacc.2014.02.537 Vahanian, 2012, Guidelines on the management of valvular heart disease (version 2012), Eur Heart J, 33, 2451, 10.1093/eurheartj/ehs109 Inoue, 1991, Percutaneous transvenous mitral commissurotomy using the Inoue balloon, Eur Heart J, 12, S99, 10.1093/eurheartj/12.suppl_B.99 Therkelsen, 2008, ANP and BNP in atrial fibrillation before and after cardioversion and their relationship to cardiac volume and function, Int J Cardiol, 127, 396, 10.1016/j.ijcard.2007.04.059 Sacher, 2008, Chronic atrial fibrillation ablation impact on endocrine and mechanical cardiac functions, Eur Heart, 29, 1290, 10.1093/eurheartj/ehm577